 | • レポートコード：MRC2Q12-17164 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、角膜架橋装置のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 角膜架橋装置のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 角膜架橋装置の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 角膜架橋装置のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの角膜架橋装置の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の角膜架橋装置の売上および2028年までの予測に焦点を当てています。 角膜架橋装置のグローバル主要企業には、Glaukos Corporation、EMAGine AG、Peschke GmbH、IROMED GROUP Srl、iVIS Technologies、AJL Ophthalmic S.A.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 角膜架橋装置市場は、タイプとアプリケーションによって区分されます。世界の角膜架橋装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 標準角膜架橋、角膜架橋プラス、加速架橋 【アプリケーション別セグメント】 円錐角膜、ペルーシド角膜変性症、屈折矯正手術 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 角膜架橋装置製品概要 - タイプ別市場（標準角膜架橋、角膜架橋プラス、加速架橋） - アプリケーション別市場（円錐角膜、ペルーシド角膜変性症、屈折矯正手術） - 調査の目的 ・エグゼクティブサマリー - 世界の角膜架橋装置販売量予測2017-2028 - 世界の角膜架橋装置売上予測2017-2028 - 角膜架橋装置の地域別販売量 - 角膜架橋装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別角膜架橋装置販売量 - 主要メーカー別角膜架橋装置売上 - 主要メーカー別角膜架橋装置価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（標準角膜架橋、角膜架橋プラス、加速架橋） - 角膜架橋装置のタイプ別販売量 - 角膜架橋装置のタイプ別売上 - 角膜架橋装置のタイプ別価格 ・アプリケーション別市場規模（円錐角膜、ペルーシド角膜変性症、屈折矯正手術） - 角膜架橋装置のアプリケーション別販売量 - 角膜架橋装置のアプリケーション別売上 - 角膜架橋装置のアプリケーション別価格 ・北米市場 - 北米の角膜架橋装置市場規模（タイプ別、アプリケーション別） - 主要国別の角膜架橋装置市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの角膜架橋装置市場規模（タイプ別、アプリケーション別） - 主要国別の角膜架橋装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の角膜架橋装置市場規模（タイプ別、アプリケーション別） - 主要国別の角膜架橋装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の角膜架橋装置市場規模（タイプ別、アプリケーション別） - 主要国別の角膜架橋装置市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの角膜架橋装置市場規模（タイプ別、アプリケーション別） - 主要国別の角膜架橋装置市場規模（トルコ、サウジアラビア） ・企業情報 Glaukos Corporation、EMAGine AG、Peschke GmbH、IROMED GROUP Srl、iVIS Technologies、AJL Ophthalmic S.A. ・産業チェーン及び販売チャネル分析 - 角膜架橋装置の産業チェーン分析 - 角膜架橋装置の原材料 - 角膜架橋装置の生産プロセス - 角膜架橋装置の販売及びマーケティング - 角膜架橋装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 角膜架橋装置の産業動向 - 角膜架橋装置のマーケットドライバー - 角膜架橋装置の課題 - 角膜架橋装置の阻害要因 ・主な調査結果 |
Corneal cross-linking is a treatment for an eye problem called keratoconus.In corneal cross-linking, doctors use eyedrop medication and ultraviolet (UV) light from a special machine to make the tissues in your cornea stronger. The goal is to keep the cornea from bulging more.It’s called “cross-linking” because it adds bonds between the collagen fibers in your eye. They work like support beams to help the cornea stay stable.
Corneal cross-linking is the only treatment that can stop progressive keratoconus from getting worse.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Corneal Cross Linking Device estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Corneal Cross Linking Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Corneal Cross Linking Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Corneal Cross Linking Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Corneal Cross Linking Device include Glaukos Corporation, EMAGine AG, Peschke GmbH, IROMED GROUP Srl, iVIS Technologies and AJL Ophthalmic S.A., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Corneal Cross Linking Device companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Corneal Cross Linking Device market. Further, it explains the major drivers and regional dynamics of the global Corneal Cross Linking Device market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Glaukos Corporation
EMAGine AG
Peschke GmbH
IROMED GROUP Srl
iVIS Technologies
AJL Ophthalmic S.A.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Corneal Cross Linking Device Segment by Type
Standard Corneal Cross Linking
Corneal Cross Linking Plus
Accelerated Cross Linking
Corneal Cross Linking Device Segment by Application
Keratoconus
Pellucid Marginal Degeneration
Refractive Surgery Ectasia
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Corneal Cross Linking Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Corneal Cross Linking Device market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Corneal Cross Linking Device, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Corneal Cross Linking Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Corneal Cross Linking Device revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Corneal Cross Linking Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Corneal Cross Linking Device revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Glaukos Corporation, EMAGine AG, Peschke GmbH, IROMED GROUP Srl, iVIS Technologies and AJL Ophthalmic S.A., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Corneal Cross Linking Device in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Corneal Cross Linking Device companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Corneal Cross Linking Device revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Corneal Cross Linking Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Standard Corneal Cross Linking
1.2.3 Corneal Cross Linking Plus
1.2.4 Accelerated Cross Linking
1.3 Market by Application
1.3.1 Global Corneal Cross Linking Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Keratoconus
1.3.3 Pellucid Marginal Degeneration
1.3.4 Refractive Surgery Ectasia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Corneal Cross Linking Device Market Perspective (2017-2028)
2.2 Corneal Cross Linking Device Growth Trends by Region
2.2.1 Corneal Cross Linking Device Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Corneal Cross Linking Device Historic Market Size by Region (2017-2022)
2.2.3 Corneal Cross Linking Device Forecasted Market Size by Region (2023-2028)
2.3 Corneal Cross Linking Device Market Dynamics
2.3.1 Corneal Cross Linking Device Industry Trends
2.3.2 Corneal Cross Linking Device Market Drivers
2.3.3 Corneal Cross Linking Device Market Challenges
2.3.4 Corneal Cross Linking Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Corneal Cross Linking Device Players by Revenue
3.1.1 Global Top Corneal Cross Linking Device Players by Revenue (2017-2022)
3.1.2 Global Corneal Cross Linking Device Revenue Market Share by Players (2017-2022)
3.2 Global Corneal Cross Linking Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Corneal Cross Linking Device Revenue
3.4 Global Corneal Cross Linking Device Market Concentration Ratio
3.4.1 Global Corneal Cross Linking Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Corneal Cross Linking Device Revenue in 2021
3.5 Corneal Cross Linking Device Key Players Head office and Area Served
3.6 Key Players Corneal Cross Linking Device Product Solution and Service
3.7 Date of Enter into Corneal Cross Linking Device Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Corneal Cross Linking Device Breakdown Data by Type
4.1 Global Corneal Cross Linking Device Historic Market Size by Type (2017-2022)
4.2 Global Corneal Cross Linking Device Forecasted Market Size by Type (2023-2028)
5 Corneal Cross Linking Device Breakdown Data by Application
5.1 Global Corneal Cross Linking Device Historic Market Size by Application (2017-2022)
5.2 Global Corneal Cross Linking Device Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Corneal Cross Linking Device Market Size (2017-2028)
6.2 North America Corneal Cross Linking Device Market Size by Type
6.2.1 North America Corneal Cross Linking Device Market Size by Type (2017-2022)
6.2.2 North America Corneal Cross Linking Device Market Size by Type (2023-2028)
6.2.3 North America Corneal Cross Linking Device Market Share by Type (2017-2028)
6.3 North America Corneal Cross Linking Device Market Size by Application
6.3.1 North America Corneal Cross Linking Device Market Size by Application (2017-2022)
6.3.2 North America Corneal Cross Linking Device Market Size by Application (2023-2028)
6.3.3 North America Corneal Cross Linking Device Market Share by Application (2017-2028)
6.4 North America Corneal Cross Linking Device Market Size by Country
6.4.1 North America Corneal Cross Linking Device Market Size by Country (2017-2022)
6.4.2 North America Corneal Cross Linking Device Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Corneal Cross Linking Device Market Size (2017-2028)
7.2 Europe Corneal Cross Linking Device Market Size by Type
7.2.1 Europe Corneal Cross Linking Device Market Size by Type (2017-2022)
7.2.2 Europe Corneal Cross Linking Device Market Size by Type (2023-2028)
7.2.3 Europe Corneal Cross Linking Device Market Share by Type (2017-2028)
7.3 Europe Corneal Cross Linking Device Market Size by Application
7.3.1 Europe Corneal Cross Linking Device Market Size by Application (2017-2022)
7.3.2 Europe Corneal Cross Linking Device Market Size by Application (2023-2028)
7.3.3 Europe Corneal Cross Linking Device Market Share by Application (2017-2028)
7.4 Europe Corneal Cross Linking Device Market Size by Country
7.4.1 Europe Corneal Cross Linking Device Market Size by Country (2017-2022)
7.4.2 Europe Corneal Cross Linking Device Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Corneal Cross Linking Device Market Size (2017-2028)
8.2 Asia-Pacific Corneal Cross Linking Device Market Size by Type
8.2.1 Asia-Pacific Corneal Cross Linking Device Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Corneal Cross Linking Device Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Corneal Cross Linking Device Market Share by Type (2017-2028)
8.3 Asia-Pacific Corneal Cross Linking Device Market Size by Application
8.3.1 Asia-Pacific Corneal Cross Linking Device Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Corneal Cross Linking Device Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Corneal Cross Linking Device Market Share by Application (2017-2028)
8.4 Asia-Pacific Corneal Cross Linking Device Market Size by Region
8.4.1 Asia-Pacific Corneal Cross Linking Device Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Corneal Cross Linking Device Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Corneal Cross Linking Device Market Size (2017-2028)
9.2 Latin America Corneal Cross Linking Device Market Size by Type
9.2.1 Latin America Corneal Cross Linking Device Market Size by Type (2017-2022)
9.2.2 Latin America Corneal Cross Linking Device Market Size by Type (2023-2028)
9.2.3 Latin America Corneal Cross Linking Device Market Share by Type (2017-2028)
9.3 Latin America Corneal Cross Linking Device Market Size by Application
9.3.1 Latin America Corneal Cross Linking Device Market Size by Application (2017-2022)
9.3.2 Latin America Corneal Cross Linking Device Market Size by Application (2023-2028)
9.3.3 Latin America Corneal Cross Linking Device Market Share by Application (2017-2028)
9.4 Latin America Corneal Cross Linking Device Market Size by Country
9.4.1 Latin America Corneal Cross Linking Device Market Size by Country (2017-2022)
9.4.2 Latin America Corneal Cross Linking Device Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Corneal Cross Linking Device Market Size (2017-2028)
10.2 Middle East & Africa Corneal Cross Linking Device Market Size by Type
10.2.1 Middle East & Africa Corneal Cross Linking Device Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Corneal Cross Linking Device Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Corneal Cross Linking Device Market Share by Type (2017-2028)
10.3 Middle East & Africa Corneal Cross Linking Device Market Size by Application
10.3.1 Middle East & Africa Corneal Cross Linking Device Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Corneal Cross Linking Device Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Corneal Cross Linking Device Market Share by Application (2017-2028)
10.4 Middle East & Africa Corneal Cross Linking Device Market Size by Country
10.4.1 Middle East & Africa Corneal Cross Linking Device Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Corneal Cross Linking Device Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Glaukos Corporation
11.1.1 Glaukos Corporation Company Details
11.1.2 Glaukos Corporation Business Overview
11.1.3 Glaukos Corporation Corneal Cross Linking Device Introduction
11.1.4 Glaukos Corporation Revenue in Corneal Cross Linking Device Business (2017-2022)
11.1.5 Glaukos Corporation Recent Developments
11.2 EMAGine AG
11.2.1 EMAGine AG Company Details
11.2.2 EMAGine AG Business Overview
11.2.3 EMAGine AG Corneal Cross Linking Device Introduction
11.2.4 EMAGine AG Revenue in Corneal Cross Linking Device Business (2017-2022)
11.2.5 EMAGine AG Recent Developments
11.3 Peschke GmbH
11.3.1 Peschke GmbH Company Details
11.3.2 Peschke GmbH Business Overview
11.3.3 Peschke GmbH Corneal Cross Linking Device Introduction
11.3.4 Peschke GmbH Revenue in Corneal Cross Linking Device Business (2017-2022)
11.3.5 Peschke GmbH Recent Developments
11.4 IROMED GROUP Srl
11.4.1 IROMED GROUP Srl Company Details
11.4.2 IROMED GROUP Srl Business Overview
11.4.3 IROMED GROUP Srl Corneal Cross Linking Device Introduction
11.4.4 IROMED GROUP Srl Revenue in Corneal Cross Linking Device Business (2017-2022)
11.4.5 IROMED GROUP Srl Recent Developments
11.5 iVIS Technologies
11.5.1 iVIS Technologies Company Details
11.5.2 iVIS Technologies Business Overview
11.5.3 iVIS Technologies Corneal Cross Linking Device Introduction
11.5.4 iVIS Technologies Revenue in Corneal Cross Linking Device Business (2017-2022)
11.5.5 iVIS Technologies Recent Developments
11.6 AJL Ophthalmic S.A.
11.6.1 AJL Ophthalmic S.A. Company Details
11.6.2 AJL Ophthalmic S.A. Business Overview
11.6.3 AJL Ophthalmic S.A. Corneal Cross Linking Device Introduction
11.6.4 AJL Ophthalmic S.A. Revenue in Corneal Cross Linking Device Business (2017-2022)
11.6.5 AJL Ophthalmic S.A. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer